Fingerprint
Dive into the research topics of 'A phase II study alternating erlotinib with second-line mFOLFOX6 or FOLFIRI for metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study alternating erlotinib with second-line mFOLFOX6 or FOLFIRI for metastatic colorectal cancer
Matthew R. Kearney, Emerson Y. Chen, Gina M. Vaccaro, John Strother, Andrea Burt, Kendra Todd, Jeff Donovan, Kerstin M. Kampa-Schittenhelm, Charles D. Lopez
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations